Overview of AOD 9604

AOD 9604, short for Anti-Obesity Drug 9604, is a modified fragment of the human growth hormone (hGH) molecule, specifically representing amino acids 176–191 of the hGH C-terminus. Originally developed at Monash University in Australia during the 1990s, this 16-amino-acid peptide was engineered to isolate the fat-burning properties of growth hormone without the growth-promoting or insulin-related side effects typically associated with full-length hGH.

Each vial available from SteroidsCanada.is contains a precisely measured 5MG of lyophilized AOD 9604, manufactured to rigorous pharmaceutical-grade standards and third-party tested for purity exceeding 98%. This makes it an ideal choice for researchers, biohackers, and wellness enthusiasts seeking a dependable, high-quality peptide for fat-loss studies and metabolic research.

How AOD 9604 Works

Unlike traditional weight-loss compounds that suppress appetite or stimulate the central nervous system, AOD 9604 operates through a more elegant biological mechanism. It mimics the way natural growth hormone regulates fat metabolism by stimulating lipolysis (the breakdown of stored fat) and inhibiting lipogenesis (the creation of new fat cells). It achieves this by binding to beta-3 adrenergic receptors in adipose tissue, effectively signalling the body to use fat as fuel.

What makes AOD 9604 especially attractive is its selective action. It targets adipose tissue without negatively affecting blood sugar levels, insulin sensitivity, or IGF-1 pathways — distinguishing it from full-sequence hGH and other peptide alternatives.

Key Benefits

Product Specifications

Dosage and Usage Guidelines

AOD 9604 is most commonly administered via subcutaneous injection using an insulin syringe (29–31 gauge). The peptide must first be reconstituted with bacteriostatic water before use. A typical reconstitution involves adding 2 mL of bacteriostatic water to the 5 MG vial, resulting in a concentration of 2500 mcg per mL — meaning 10 IU on an insulin syringe equals 250 mcg.

Standard Dosing Protocol

• Beginner Dose: 250–300 mcg once daily
• Standard Dose: 300–500 mcg once daily
• Advanced Dose: Up to 600 mcg once daily (rarely required)
• Cycle Length: 12 weeks on, 4 weeks off is a widely used framework

Optimal Timing

For maximum effectiveness, AOD 9604 should be administered first thing in the morning on an empty stomach. This takes advantage of naturally elevated growth hormone activity and low insulin levels, both of which enhance lipolytic efficiency. Some users also split their dose into two smaller injections — one upon waking and one before bed — to maintain steady plasma levels throughout the day.

Injection Site Rotation

Common subcutaneous injection sites include the abdomen (at least 2 inches from the navel), the love-handle area, and the upper thigh. Rotating sites prevents lipoatrophy and ensures consistent absorption.

Reconstitution Math — Quick Reference

If you add 2 mL of bacteriostatic water to a 5 MG vial, here’s the calculation:

Therefore, on a standard 100 IU insulin syringe, here’s what each measurement equals:

What to Expect — Timeline of Results

While individual responses vary, most users following a consistent protocol paired with proper nutrition and exercise typically report noticeable changes across the following timeline:

• Weeks 1–2: Subtle increase in energy, improved morning alertness
• Weeks 3–4: Visible reduction in bloating and measurable fat loss around the midsection
• Weeks 5–8: More defined muscle tone, improved joint comfort, accelerated fat loss
• Weeks 9–12: Peak recomposition benefits — leaner physique, enhanced vascularity, better sleep quality

Stacking Possibilities

AOD 9604 is often stacked with synergistic peptides for amplified results. Popular combinations include:

• AOD 9604 + CJC-1295 / Ipamorelin: Enhanced fat loss with added growth hormone pulsing
• AOD 9604 + BPC-157: Fat loss paired with healing and gut-repair benefits
• AOD 9604 + Tesamorelin: Targeted visceral fat reduction

Side Effects and Safety

AOD 9604 is consistently ranked among the safest peptides available. Clinical studies have shown it to be well-tolerated even at doses significantly higher than typical user protocols. Reported side effects are minimal and may include:

• Mild injection-site redness or swelling
• Occasional light-headedness during the first week
• Temporary digestive adjustment

Because AOD 9604 does not influence IGF-1, blood sugar, or insulin, it avoids the common pitfalls of traditional growth-hormone therapy.

Why Choose SteroidsCanada.is?

• ✅ Pharmaceutical-grade AOD 9604 — lab tested for purity and potency
• ✅ Discreet, tracked shipping across Canada
• ✅ Proper cold-chain handling to preserve peptide integrity
• ✅ Responsive customer service and reliable restocking
• ✅ Competitive Canadian pricing with no hidden fees